Literature DB >> 18394008

Three-layered structure shared between Lewy bodies and lewy neurites-three-dimensional reconstruction of triple-labeled sections.

Toshiro Kanazawa1, Toshiki Uchihara, Atsushi Takahashi, Ayako Nakamura, Satoshi Orimo, Hidehiro Mizusawa.   

Abstract

Lewy bodies (LBs) and Lewy neurites (LNs) are the hallmarks of Parkinson's disease (PD). Although LBs and LNs, frequently coexistent, share some histological properties, their appearances are quite different under conventional two-dimensional observation. In order to clarify how these apparently different structures (LBs and LNs) are related during their formation, we performed three-dimensional observation on post-mortem brainstem tissues with PD. Sixty-microm thick floating sections were multi-immunofluorolabeled for alpha-synuclein (alphaS), ubiquitin (Ub) and neurofilament (NF). Serial confocal images were reconstructed with software. External three-dimensional configuration of LBs, double-labeled for alphaS and NF, exhibited frequent continuity with LNs (70%). Internally, alphaS and Ub formed the three-dimensional concentric inner layers and NF rimmed these inner layers. This layered structure was shared among spherical LBs, rod-shaped LNs and even convoluted forms of LBs/LNs. Furthermore, each layer exhibited continuity without interruption even in the convoluted form and around its junction to spherical LBs. This three-layered structure shared among various Lewy pathologies and their layered continuity on three-dimensional basis favor the hypothesis that LNs evolve into LBs. Besides progression from pale bodies to LBs, structural evolution from LNs into LBs may provide an alternative explanation for the variability of alphaS deposits and their interrelation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18394008     DOI: 10.1111/j.1750-3639.2008.00140.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  18 in total

1.  Altered neurofilament protein expression in the lateral vestibular nucleus in Parkinson's disease.

Authors:  Thomas P Wellings; Alan M Brichta; Rebecca Lim
Journal:  Exp Brain Res       Date:  2017-09-19       Impact factor: 1.972

Review 2.  Staging neurodegenerative disorders: structural, regional, biomarker, and functional progressions.

Authors:  Trevor Archer; Richard M Kostrzewa; Richard J Beninger; Tomas Palomo
Journal:  Neurotox Res       Date:  2011-02       Impact factor: 3.911

Review 3.  Reverse engineering Lewy bodies: how far have we come and how far can we go?

Authors:  Mohamed Bilal Fares; Somanath Jagannath; Hilal A Lashuel
Journal:  Nat Rev Neurosci       Date:  2021-01-11       Impact factor: 34.870

4.  Novel conformation-selective alpha-synuclein antibodies raised against different in vitro fibril forms show distinct patterns of Lewy pathology in Parkinson's disease.

Authors:  D J Covell; J L Robinson; R S Akhtar; M Grossman; D Weintraub; H M Bucklin; R M Pitkin; D Riddle; A Yousef; J Q Trojanowski; V M-Y Lee
Journal:  Neuropathol Appl Neurobiol       Date:  2017-05-15       Impact factor: 8.090

Review 5.  Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update-I. Hypokinetic-rigid movement disorders.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2019-06-18       Impact factor: 3.575

Review 6.  Formation and development of Lewy pathology: a critical update.

Authors:  Kurt A Jellinger
Journal:  J Neurol       Date:  2009-08       Impact factor: 4.849

7.  Critical role of truncated α-synuclein and aggregates in Parkinson's disease and incidental Lewy body disease.

Authors:  Kavita Prasad; Thomas G Beach; John Hedreen; Eric K Richfield
Journal:  Brain Pathol       Date:  2012-05-23       Impact factor: 6.508

8.  Mitochondrial dysfunction in Parkinson's disease.

Authors:  P C Keane; M Kurzawa; P G Blain; C M Morris
Journal:  Parkinsons Dis       Date:  2011-03-15

9.  α-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson's disease and multiple system atrophy?

Authors:  Aoife P Kiely; Yasmine T Asi; Eleanna Kara; Patricia Limousin; Helen Ling; Patrick Lewis; Christos Proukakis; Niall Quinn; Andrew J Lees; John Hardy; Tamas Revesz; Henry Houlden; Janice L Holton
Journal:  Acta Neuropathol       Date:  2013-02-12       Impact factor: 17.088

10.  Mitochondrial quality, dynamics and functional capacity in Parkinson's disease cybrid cell lines selected for Lewy body expression.

Authors:  Emily N Cronin-Furman; M Kathleen Borland; Kristen E Bergquist; James P Bennett; Patricia A Trimmer
Journal:  Mol Neurodegener       Date:  2013-01-26       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.